Nivolumab-associated extragenital lichen sclerosus et atrophicus

Clin Exp Dermatol. 2020 Apr;45(3):350-352. doi: 10.1111/ced.14092. Epub 2019 Oct 11.

Authors

N di Meo¹, C Conforti¹, P Corneli¹, R Vezzoni¹, C Retrosi¹, M A Pizzichetta², G M Rizzi¹, I Zalaudek¹

Affiliations

¹ Department of Dermatology, Maggiore Hospital, University of Trieste, Trieste, Italy.
² Division of Medical Oncology - Preventive Oncology, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Italy.

PMID: 31498907
DOI: 10.1111/ced.14092

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Breast
Drug Eruptions / etiology*
Female
Humans
Lichen Sclerosus et Atrophicus / chemically induced*
Nivolumab / adverse effects*

Substances

Nivolumab